// STATE LEGISLATION TRACKER

Rhode Island HB 7923 — AN ACT RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Rhode Island
Bill: HB 7923
Session: 2026
Filed: 2026-02-27
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Based only on the title and available metadata, HB7923 appears to relate to Rhode Island's controlled substances law. No peptide-specific text, compounding language, telehealth language, or scope-of-practice changes are available from the provided record, so there is no clear peptide-ecosystem impact.

Key Points

No peptide-specific provision is visible from the available metadata
No 503A or 503B compounding change is shown
No telehealth prescribing change is shown
Controlled-substance changes usually do not affect most peptides unless a peptide is scheduled

What to Watch For

Note Watch for full bill text before assuming any impact on compounded peptides or off-label prescribing.

Concern If later text changes controlled-substance prescribing rules, clinics may face extra prescribing or monitoring steps.

Note No recorded actions means the bill's process status is unclear from the provided source.

Where the Bill Stands

The provided record says there are no actions recorded, so the bill's exact position in the legislative process cannot be confirmed.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws